Analysts on Wall Street project that Walt Disney (DIS) will announce quarterly earnings of $1.03 per share in its forthcoming report, representing a decline of 9.7% year over year. Revenues are projected to reach $22.88 billion, increasing 1.4% from the same quarter last year.The current level reflects a downward revision of 0.4% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections o ...

The upcoming report from Pan American Silver (PAAS) is expected to reveal quarterly earnings of $0.49 per share, indicating an increase of 53.1% compared to the year-ago period. Analysts forecast revenues of $867.76 million, representing an increase of 21.2% year over year.The consensus EPS estimate for the quarter has been revised 17.6% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timef ...

Wall Street analysts forecast that GlobalFoundries Inc. (GFS) will report quarterly earnings of $0.38 per share in its upcoming release, pointing to a year-over-year decline of 7.3%. It is anticipated that revenues will amount to $1.68 billion, exhibiting a decrease of 3.7% compared to the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course ...

In its upcoming report, Cisco Systems (CSCO) is predicted by Wall Street analysts to post quarterly earnings of $0.98 per share, reflecting an increase of 7.7% compared to the same period last year. Revenues are forecasted to be $14.78 billion, representing a year-over-year increase of 6.8%.The current level reflects a downward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initia ...

Core Insights - Health Catalyst (HCAT) is expected to report quarterly earnings of $0.05 per share, reflecting a year-over-year decline of 28.6% [1] - Revenue projections stand at $75.08 million, indicating a decrease of 1.7% compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, suggesting analysts have reevaluated their initial estimates [1][2] Revenue Estimates - Analysts predict 'Revenue- Professional services' will reach $23.08 million, a decline of 16.7% from the prior-year quarter [4] - 'Revenue- Technology' is estimated at $52.00 million, showing a year-over-year increase of 6.9% [4] Profit Estimates - The average prediction for 'Adjusted Gross Profit- Professional Services' is $4.45 million, down from $4.72 million reported in the same quarter last year [5] - The consensus estimate for 'Adjusted Gross Profit- Technology' is $34.90 million, compared to $31.57 million reported in the same quarter last year [5] Stock Performance - Health Catalyst shares have increased by 7% over the past month, outperforming the Zacks S&P 500 composite, which rose by 1.3% [5] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [5]

In its upcoming report, Amdocs (DOX) is predicted by Wall Street analysts to post quarterly earnings of $1.82 per share, reflecting an increase of 7.1% compared to the same period last year. Revenues are forecasted to be $1.14 billion, representing a year-over-year decrease of 9.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. Before a ...

Core Insights - Wall Street analysts expect Kamada (KMDA) to report quarterly earnings of $0.10 per share, reflecting a year-over-year increase of 42.9% [1] - Revenue projections for Kamada are set at $46.25 million, which indicates a 10.8% increase compared to the same quarter last year [1] Earnings Estimates - There have been no revisions in the consensus EPS estimate for the quarter over the last 30 days, indicating stability in analysts' forecasts [1][2] - Changes in earnings estimates are crucial for predicting investor reactions and are strongly correlated with short-term stock performance [2] Revenue Breakdown - Analysts predict 'Revenues- Distribution' will reach $5.45 million, representing an 18.1% year-over-year increase [4] - 'Revenues- Proprietary products' are expected to be $40.80 million, showing a 9.9% year-over-year growth [4] - The estimated 'Gross Profit- Proprietary products' is projected to be $18.81 million, compared to $16.26 million from the previous year [4] Stock Performance - Over the past month, Kamada's shares have returned +1%, slightly underperforming the Zacks S&P 500 composite's +1.3% [5] - Kamada currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [5]

Core Insights - Somnigroup International (SGI) is expected to report quarterly earnings of $0.85 per share, reflecting a 3.7% increase year over year, with revenues projected at $2.07 billion, a significant 59% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 4.2% in the last 30 days, indicating analysts' reassessment of their initial projections [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts estimate 'Net Sales- Direct' at $1.32 billion, representing a remarkable increase of 316.1% from the previous year [5]. - 'Net Sales- Wholesale' is projected to be $716.71 million, indicating a decrease of 27% year over year [5]. - 'Net Sales- International' is expected to reach $308.79 million, reflecting an 8.5% increase from the prior year [5]. Regional Sales Estimates - 'Net Sales- North America' is anticipated to be $732.72 million, showing a decline of 27.8% from the previous year [6]. - 'Net Sales- North America- Wholesale' is forecasted at $605.19 million, indicating a year-over-year decrease of 31.1% [6]. - 'Net Sales- International- Direct' is estimated at $196.52 million, reflecting an 8.4% increase from the prior year [6]. Additional Sales Insights - 'Net Sales- International- Wholesale' is projected to be $111.52 million, suggesting a year-over-year increase of 7.9% [7]. - 'Net Sales- North America- Direct' is expected to reach $107.39 million, indicating a decline of 21.6% year over year [7]. Market Performance - SGI shares have shown a return of -4.4% over the past month, contrasting with the Zacks S&P 500 composite's +1% change [7]. - With a Zacks Rank 2 (Buy), SGI is anticipated to outperform the overall market in the near future [7].

Core Viewpoint - Wall Street analysts predict that Globus Medical (GMED) will report quarterly earnings of $0.79 per share, reflecting a year-over-year decline of 4.8%, while revenues are expected to reach $733.45 million, marking a 17.2% increase compared to the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been revised downward by 1.3%, indicating a collective reassessment by covering analysts [2]. - Revisions to earnings estimates are crucial as they serve as significant indicators for predicting potential investor actions regarding the stock [3]. Revenue Projections - Analysts expect 'Net Sales by Product Category - Enabling Technologies' to be $40.23 million, showing a year-over-year increase of 5% [5]. - The consensus for 'Net Sales by Product Category - Musculoskeletal Solutions' is projected at $693.98 million, reflecting an 18.1% increase from the prior-year quarter [5]. - The average prediction for 'Geographic Revenues - International' is $144.37 million, indicating an 11.1% increase from the year-ago quarter [6]. - 'Geographic Revenues - United States' are forecasted to reach $589.84 million, representing a 19% increase from the prior-year quarter [6]. Stock Performance - Globus Medical shares have increased by 4% over the past month, outperforming the Zacks S&P 500 composite, which has seen a 1% increase [6]. - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6].

Core Insights - Tyson Foods (TSN) is expected to report quarterly earnings of $0.85 per share, reflecting a decline of 7.6% year-over-year, while revenues are forecasted to reach $13.91 billion, indicating a 2.5% increase compared to the previous year [1] Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been revised upward by 5.1%, indicating analysts' reassessment of their initial forecasts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock price performance [3] Sales Projections - Analysts project 'Sales- Chicken' to reach $4.30 billion, reflecting a year-over-year increase of 1.1% [4] - 'Sales- Beef' is expected to be $5.45 billion, indicating a 3.7% increase from the previous year [5] - 'Sales- International/Other' is forecasted at $612.05 million, showing a 0.5% increase year-over-year [5] - 'Sales- Prepared Foods' is estimated to reach $2.51 billion, suggesting a 1.5% increase compared to the prior year [5] - 'Sales- Pork' is projected to be $1.52 billion, indicating a 6% increase year-over-year [6] Adjusted Operating Income Estimates - The consensus for 'Adjusted Operating Income (Loss)- Pork' is estimated at $23.28 million, up from $19.00 million in the previous year [6] - 'Adjusted Operating Income (Loss)- International/Other' is projected at $13.80 million, compared to $3.00 million reported in the same quarter last year [7] - 'Adjusted Operating Income (Loss)- Prepared Foods' is expected to be $212.35 million, up from $205.00 million year-over-year [7]